Form 4: Rocket Pharmaceuticals CEO Sells Shares
Insider Transaction (Form 4)
Gaurav Shah, CEO of Rocket Pharmaceuticals, Inc., sold 2,293 shares of common stock on August 18, 2026 for $3.38 per share.
Summary
- Open-market sale: disposed of 2,293 Common Stock at $3.38 ($7,753) on August 18, 2026; holds 1,056,594 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $7,753 of stock on the open market.
Insider Transactions
Gaurav Shah — Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 2,293 | $3 | $7.8K | 1,056,594 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (2,293 shares) |
Keywords
insider transaction, Form 4, RCKT, ROCKET PHARMACEUTICALS, INC., bearish, Gaurav Shah
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.